HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Peter Feindt Emmeran Gams Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sunderdiek, U. Articles by Gams, E. Search for Related Content PubMed PubMed Citation Articles by Sunderdiek, U. Articles by Gams, E.

Eur J Cardiothorac Surg 2000;18:393-399
© 2000 Elsevier Science NL

Aortocoronary bypass grafting: a comparison of HTK cardioplegia vs. intermittent aortic cross-clamping

Department of Thoracic and Cardiovascular Surgery; Heinrich-Heine-University, Moorenstrasse 5, 40225 Düsseldorf, Germany

Received 7 September 1999; received in revised form 26 May 2000; accepted 31 May 2000.

Corresponding author. Tel.: +49-211-8118331; fax: +49-211-8118333
e-mail: usunderdiek{at}aol.com

Objective: Intermittend, hypothermic aortic cross-clamping (IAC) with myocardial fibrillation and cardioplegic arrest (CA) have been established both as effective methods for coronary artery bypass surgery (CABG). Nevertheless, there exists controversy about the more beneficial cardioprotective effect of one of these procedures in CABG-patients. Methods: In this prospective study we compared the clinical outcome, ischemic serum-markers (CK, CK-MB, Troponin I), electrocardiogram (ECG)-changes, and hemodynamic data of 103 patients. Randomization in group I (IAC; n=52) or group II (CA; n=51) was done consecutively, all data were compared by Student’s t-test or ²-test and P<0.05 was regarded as significant. The Bretschneider–HTK solution was used for cardioplegic arrest. Data were collected before operation, before ischemic arrest, after 5 and 60 min of reperfusion, 1 and 6 h after operation, 1, 2 and 10 days postoperatively. Results: There were no significant differences between both groups regarding general patient data: age (IAC: 64.8±9.2 vs. CA: 63.8±9.0 years), left ventricular function (ejection fraction: IAC: 62±14 vs. CA: 64±13%), the amount of bypassed vessels (IAC: 3.4±0.5 vs. CA: 3.6±0.5), total bypass time (IAC: 113±31 vs. CA 108±20 min). The total time of ischemia was significantly less in the IAC group with 37±10 vs. 48±10 min in the CA group. In the IAC-group, a higher mortality was noticed (7.7 vs. 3.9%; N.S.). This was combined with a significantly higher amount of patients with peak serum-values of CK-MB (>40 U/l) and troponin I (>50 ng/ml), 17 in the IAC-group (33%) vs. eight in CA-group (16%). Cerebral strokes were seen in two IAC-patients and none in CA-patients (NS). ECG-changes occurred in 22 IAC patients (42%) vs. 16 CA patients (31%); persistent ischemia related ECG-changes in six IAC (11.5%) vs. five CA-patients (9.8%). Conclusions: Both cardioprotective methods, IAC and HTK-cardioplegia, seem to offer sufficient myocardial protection in normal CABG-procedures. Although neurologic disorders and mortality rates were higher in patients with intermittent aortic cross-clamping, the differences to the cardioplegia group were not significant. According to the analysis of increased ECG-changes, higher CK-MB and troponin I values, which occurred especially in patients with myocardial ischemia time longer than 40 min, we conclude that cardioplegic arrest with HTK seems to offer more beneficial effects in procedures with prolonged ischemia.

Key Words: Coronary surgery • Intermittent aortic cross-clamping • Cardioplegia • Troponin I

This article has been cited by other articles:

				M. Fujii and D. J. Chambers Myocardial protection with intermittent cross-clamp fibrillation: does preconditioning play a role? Eur. J. Cardiothorac. Surg., December 1, 2005; 28(6): 821 - 831. [Abstract] [Full Text] [PDF]

				M. Fujii, M. Avkiran, and D. J Chambers Experimental studies on myocardial protection with intermittent cross-clamp fibrillation: additive effect of the sodium-hydrogen exchanger inhibitor, cariporide Ann. Thorac. Surg., April 1, 2004; 77(4): 1398 - 1407. [Abstract] [Full Text] [PDF]

				U. Sunderdiek, S. Schmitz-Spanke, B. Korbmacher, E. Gams, and J. D. Schipke Left ventricular dysfunction and disturbed O2-utilization in stunned myocardium: influence of ischemic preconditioning Eur. J. Cardiothorac. Surg., October 1, 2001; 20(4): 770 - 776. [Abstract] [Full Text] [PDF]